Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Marie-Caroline CotelAnthony C Vernon

Abstract

Neuroinflammation is increasingly implicated in the pathogenesis of Schizophrenia (SCZ). In addition, there is increasing evidence for a relationship between the dose and duration of antipsychotic drug (APD) treatment and reductions in grey matter volume. The potential contribution of microglia to these phenomena is however not yet defined. Adult rats were treated with a common vehicle, haloperidol (HAL, 2 mg/kg/day) or olanzapine (OLZ, 10 mg/kg/day) for 8 weeks via an osmotic mini-pump implanted subcutaneously. Microglial cells, identified by their Iba-1 immunoreactivity, were quantified in four regions of interest chosen based on previous neuroimaging data: the hippocampus, anterior cingulate cortex, corpus striatum, and secondary somatosensory cortex. Those cells were also analysed according to their morphology, providing an index of their activation state. Chronic APD treatment resulted in increased density of total microglia in the hippocampus, striatum, and somatosensory cortex, but not in the ACC. Importantly, in all brain regions studied, both APD tested led to a dramatic shift towards an amoeboid, reactive, microglial morphology after chronic treatment compared to vehicle-treated controls. These data provide the first ...Continue Reading

References

Sep 7, 1999·Neuroscience Letters·T A BayerP Falkai
Jan 5, 2000·The American Journal of Psychiatry·I C WrightE T Bullmore
Mar 21, 2001·Biological Psychiatry·J LiebermanR Bilder
Oct 16, 2002·Glia·Richard B Banati
Feb 28, 2003·The Journal of Pharmacology and Experimental Therapeutics·Shitij KapurJose N Nobrega
Jan 18, 2005·Neuroscience·C Schmitz, P R Hof
Mar 10, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Karl-Anton Dorph-PetersenDavid A Lewis
Apr 6, 2005·Archives of General Psychiatry·Jeffrey A LiebermanUNKNOWN HGDH Study Group
Jun 20, 2006·Acta Neuropathologica·Johann SteinerBernhard Bogerts
Aug 23, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Anya PedersenMatthias Rothermundt
Jan 24, 2009·European Archives of Psychiatry and Clinical Neuroscience·Daniel Martins-de-SouzaChristoph W Turck
Apr 3, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hiroaki WakeJunichi Nabekura
Oct 20, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Janine DoorduinHans C Klein
Feb 4, 2010·The American Journal of Psychiatry·Alan S Brown, Elena J Derkits
Mar 31, 2010·The International Journal of Neuropsychopharmacology·Akihiro TakanoTetsuya Suhara
Feb 9, 2011·Archives of General Psychiatry·Beng-Choon HoVincent Magnotta
Feb 25, 2011·Journal of Clinical Psychopharmacology·Geartsje BoonstraRené S Kahn
Jun 7, 2011·Biological Psychiatry·Brian J MillerBrian Kirkpatrick
Mar 20, 2012·Nature Neuroscience·Robert J ZatorreHeidi Johansen-Berg
Apr 19, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Brian J MillerPeter Buckley
Oct 16, 2012·Biological Psychiatry·Brian J MillerAndrew Mellor
Jan 15, 2013·Neuron·Helmut KettenmannAlexei Verkhratsky
Mar 29, 2014·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Gaia RizzoAlessandra Bertoldo

❮ Previous
Next ❯

Citations

Dec 15, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Jo C NeillNika Adham
Feb 3, 2018·European Archives of Psychiatry and Clinical Neuroscience·Valéria de Almeida, Daniel Martins-de-Souza
Nov 23, 2019·Schizophrenia Bulletin·Federico E TurkheimerAnthony C Vernon
Sep 26, 2020·CNS Drugs·Ayushi Anna DineshAnthony C Vernon
Aug 22, 2018·Molecular Psychiatry·Paul J HarrisonCharlotte H Harrison
Oct 26, 2018·Psychological Medicine·Tiago Reis MarquesOliver D Howes
May 20, 2020·Frontiers in Psychiatry·Livia De Picker, Manuel Morrens
Jun 6, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Mattia VeroneseFederico E Turkheimer
Mar 30, 2017·Molecular Psychiatry·T Notter, U Meyer
Jul 5, 2017·Current Treatment Options in Psychiatry·Jennifer K MelbourneRajiv P Sharma
Sep 16, 2018·Brain, Behavior, and Immunity·Katie N MurrayJoanna C Neill
Jan 8, 2021·Glia·Gijsje J L J SnijdersLot D de Witte
Mar 6, 2021·Brain, Behavior, & Immunity Health·R A NolanP J Gaskill
Jun 2, 2021·Molecular Psychiatry·Christin WeisslederCynthia Shannon Weickert
Sep 16, 2018·Brain, Behavior, and Immunity·Andreza B SonegoFrancisco S Guimarães
Oct 2, 2021·European Archives of Psychiatry and Clinical Neuroscience·Ralf BrischRainer Wolf

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Barrel cortex

Here is the latest research on barrel cortex, a region of somatosensory and motor corticies in the brain, which are used by animals that rely on whiskers for world exploration.